Valuation: DexCom, Inc.

Market Cap 32.71B 171B 28.77B 27.2B 24.67B 46.34B 3,140B 46.61B 326B 126B 1,602B 123B 120B 5,149B P/E 2026 *
34.7x
P/E 2027 * 29.2x
Enterprise Value 31.95B 167B 28.1B 26.57B 24.1B 45.26B 3,067B 45.52B 318B 123B 1,565B 120B 117B 5,029B EV / Sales 2026 *
6.11x
EV / Sales 2027 * 5.46x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-2.08%
1 week-1.76%
Current month-5.30%
1 month-4.99%
3 months+22.80%
6 months+36.07%
Current year+19.36%
1 week 8.94
Extreme 8.94
9.22
1 month 8.49
Extreme 8.49
9.51
Current year 5.75
Extreme 5.75
9.57
1 year 5.75
Extreme 5.75
9.57
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-1.76% - - 32.71B
-0.31%-1.94%-24.39%+2.91% 175B
+0.97%-2.45%-5.01%+13.74% 114B
-1.01%-4.01%-1.04%+66.14% 57.98B
+0.01%+1.73%-0.42%-30.03% 50.07B
-1.00%+0.37%+14.24%+51.55% 50.13B
+0.07%-2.79%+29.18%-9.20% 32.71B
+1.07%+9.73% - - 30.77B
+1.41%+3.83%+43.64%-0.90% 26.44B
+1.29%+6.40%+28.38%-2.83% 23.96B
Average +0.03%+1.59%+10.57%+11.42% 62.36B
Weighted average by Cap. +0.00%-0.18%-2.67%+12.45%

Financials

2026 *2027 *
Net sales 5.23B 27.3B 4.6B 4.35B 3.95B 7.41B 502B 7.45B 52.08B 20.11B 256B 19.64B 19.21B 823B 5.8B 30.27B 5.1B 4.82B 4.38B 8.22B 557B 8.26B 57.75B 22.31B 284B 21.78B 21.3B 913B
Net income 974M 5.09B 857M 810M 735M 1.38B 93.53B 1.39B 9.7B 3.75B 47.73B 3.66B 3.58B 153B 1.15B 6B 1.01B 956M 867M 1.63B 110B 1.64B 11.44B 4.42B 56.28B 4.31B 4.22B 181B
Net Debt -761M -3.97B -669M -633M -574M -1.08B -73.06B -1.08B -7.58B -2.93B -37.28B -2.86B -2.8B -120B -1.06B -5.54B -934M -883M -801M -1.5B -102B -1.51B -10.57B -4.08B -51.99B -3.99B -3.9B -167B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
25/09/26 BRL 8.940 -2.08% 2
24/09/26 BRL 9.130 +0.33% 12
23/09/26 BRL 9.100 -1.19% 44
22/09/26 BRL 9.210 +1.21% 4
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.68USD
Average target price
94.48USD
Spread / Average Target
+9.00%

Quarterly revenue - Rate of surprise